Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease

Moira S Lewitt, Gary W Boyd, Pietro Scicchitano · 2024

Read Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease by Moira S Lewitt, Gary W Boyd, Pietro Scicchitano (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11592324.txt.

Description

Moira Lewitt and co-authors review a blood protein as a possible warning sign for heart disease in a 2024 article. The protein, called IGFBP-1, helps control growth factors that steer metabolism and growth, and it also acts on its own. The liver makes it, insulin holds it down, and inflammation pushes it up.

The review weighs a confusing pattern. Low levels of the protein go with a risky profile of weight, sugar, and blood fats. Yet high levels predict worse outcomes once heart disease is present. Levels also shift with sex and age, which muddy simple readings. The authors suggest richer tests, such as measuring the protein alongside insulin output after a sugar drink, and panels that add inflammation markers, to sort out what a reading really means.

Catalog record

CREATORMoira S Lewitt, Gary W Boyd, Pietro Scicchitano
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11592324

Browse the full library · About the Tower of Babel